Startups.Bio showcases an emerging biotech startup each week, selected by the analyst team at VentureRadar from the 10,000s of companies we track.
Founded in 2020, Regain Therapeutics is pursuing a new treatment approach for Alzheimer’s disease which focuses on replenishing soluble amyloid-beta peptides in the brain rather than removing the corresponding accumulation of amyloid plaques. The company has been founded based on research discoveries and patent-pending technologies developed at Karolinska Institute in Sweden in collaboration with The […]
In the past three months we’ve featured 11 biotech startups, working on a range new approaches to tackling major diseases. You can find out more about the startups in the summaries below, or head across to the VentureRadar Database to find thousands more biotech companies like these ones. Ancilia Biosciences Ancilia Biosciences develops novel bacterial […]
Ancilia Biosciences develops novel bacterial therapies that target the viral components of the microbiome to address chronic diseases across immunology and oncology indications. The company is developing a proprietary platform that leverages the natural function of CRISPR to produce a new class of live biotherapeutics (LBPs) with engineered immunity to viral phages. These viral phages, […]